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This study examined the prevalence of self-reported depressive symptoms and the self reported somatic depressive symptoms as
measured by the Beck Depression Inventory-II (BDI-II) among patients hospitalized for acute coronary syndrome (ACS), and
explored the impact of gender on both. A convenience sample of 789 adults (248 women and 541 men) was recruited for the
study during hospital admission for ACS and participants were screened for self-reported depressive symptoms. BDI-II scores
of ≥14 indicate a moderate level of depressive symptoms and this cut-oﬀ score was used to categorize patients into depressed
and non-depressed groups. Pearson chi-square tests for independence (categorical variables) and t tests for independent samples
(continuous variables) were used for gender comparisons. Results showed that depressive symptoms during ACS episodes were
diﬀerent between women and men. Women reported greater overall depressive symptoms (BDI-II mean = 11.89, S.D. = 9.68)
than men (BDI-II mean = 9.00, S.D. = 7.93) (P<0.000). Signiﬁcantly more women (7.66%) were identiﬁed positive for somatic
depressive symptoms (sleep and appetite disturbances and fatigue) than men (2.22%) (P = 0.0003). Findings support that there
are gender diﬀerences in depressive symptoms experienced by patients hospitalized for ACS. Somatic symptoms of depression may
be important indicators of depression especially among female ACS patients.
1.Introduction
Each year 2.4 million Americans are hospitalized for acute
coronary syndrome (ACS) [1]. Growing evidence supports
that post-ACS depression is an independent risk factor for
future cardiac events and mortality [2–4], and females are
disproportionately aﬀected [5]. An estimated 7.5 million
females live with a history of ACS [1] and up to 47% of fe-
males report symptoms of depression when screened for
depression during hospitalization for ACS [6]. Depression
is the most common mental illness in females and females
have twice the risk of major depressive disorder (MDD) as
compared with males [7, 8]. Data from National Comorbid-
itySurvey(NCS)supportsthegenderdiﬀerencelifetimerisk
forMDD(21%infemalesand13%inmales)[9].Population
studies from Canada [10], Germany [11], and Switzerland
[12] all report that females are at least twice as likely as males
to suﬀer from MDD. In addition to the gender diﬀerence in
prevalence of depression episodes, the depression symptoms
thatdiﬀerbetweenmalesandfemalesareheterogeneouswith
complex clusters of depressive symptoms [13, 14].
Data from large epidemiological studies reveals that
malesandfemalesoftenreportdistinctdiﬀerencesintheself-
reported somatic depressive symptoms of depression [15–
17].Somaticdepressivesymptomsinclude sleepdisturbance,
appetite disturbance, and fatigue for at least two weeks [15–
17]. Silverstein interviewed college students and found that
female students had higher somatic depressive symptoms
than male students [18]. Self-reported data from NCS also
indicated that females reported twice the frequency of so-
matic depression symptoms as compared to males [19]. Al-
though higher rates of depression have been reported in2 Nursing Research and Practice
patients with ACS, no known studies have speciﬁcally eval-
uated gender diﬀerences in speciﬁc depressive symptoms
reported during the ACS event. The purpose of this study
was to examine the gender diﬀerences and prevalence of self-
reported depressive symptoms and self-reported somatic
depressive symptoms, as measured by the Beck Depression
Inventory II (BDI-II) [20], in patients hospitalized for ACS.
2. Methods
This was a cross-sectional observational study with a con-
venience sample of 789 adults (248 females and 541 males)
hospitalized for ACS. The study included all participants
meeting the inclusion criteria of a larger study looking at the
interactions of genetics and depression on ACS outcomes.
The overall rate for males verses females was consistent with
the gender ratio for ACS admitted to the facility. Participants
were recruited during hospital admission for ACS and were
screened for self-reported depressive symptoms, by trained
research nurses, using the BDI-II. Depression was deﬁned as
a BDI-II score of ≥14 indicating at least moderate symptoms
of depression [20].
The study was approved by the University’s Committee
fortheProtectionofHumanSubjectsInternalReviewBoard.
After informed consent was obtained, by trained research
nurses, the BDI-II was administered when the patients were
stable enough during their hospital stay to answer the ques-
tions (1–3 days after hospital admission). Inclusion criteria
consisted of a conﬁrmed diagnosis of ACS and 18 years of
age or older. ACS was deﬁned as chest pain or symptoms
suggestive of ACS lasting for more than 15 minutes with new
transient or persistent ST-wave ischemic electrocardiogram
(ECG)changesandultimatedispositionas(1)acutemyocar-
dialinfarction(AMI),includingST-waveelevationinfarction
and non-ST wave elevation infarction or (2) unstable angina
[19]. The ﬁnal ACS diagnosis was veriﬁed through their
hospital inpatient medical records.
The BDI-II is a reliable and well-validated 21-item de-
pression screening scale that uses a forced-choice 4-alterna-
tive response format that has been used in the ACS popu-
linebreak lation [20]. The BDI-II has been used for 35 years
to identify and assess depressive symptoms and reports high
reliability (.80) regardless of the population [21, 22]. The
construct validity of BDI-II has been established and has
showntobeabletodiﬀerentiatebetweendepressedandnon-
depressed individuals. Higher coeﬃcient alphas (.92 for
outpatients and .93 for college students) have been reported
for the BDI-II when compared to the previous version of the
Beck Depression Inventory (BDI) [22]. Test-retest reliability
was studied with baseline data obtained on 26 outpatients
and therapy sessions one week apart (correlation .93, P<
0.001)[22].TheinternalconsistencyoftheBDI-IIinpatients
with ACS has an alpha value of 0.87 [23]. Higher BDI-II
scores indicate a greater number of depressive symptoms.
BDI-II scores of ≥14 indicate a moderate level of depressive
symptoms [20, 24]. This cut-oﬀ score has successfully been
used to screen patients hospitalized for ACS (odds ratio,
7.82; 95% CI, 2.42 to 25.26; P = 0.0002) and the internal
consistency of the BDI-II in patients with ACS has an alpha
value of 0.87 [24].
Somatic depressive symptoms were measured using BDI-
II question 16 (sleep disturbance), question 18 (appetite dis-
turbance),andquestion20(fatigue).Apatientwasidentiﬁed
aspositiveforsomaticdepressivesymptomswhenthepatient
rated all three items as 1 or above. If a patient rated 0 on
any of the three items, he or she was categorized as negative
for somatic depressive symptoms. Pearson chi-square tests
for independence (categorical variables) or t-tests for in-
dependent samples (continuous variables) were used to
examine diﬀerences in demographic characteristics between
malesandfemales.Comparisonsofdepressionordinalscores
and symptoms by gender were conducted with Wilcoxon
rank sum and Pearson chi-square tests for independence,
respectively. Degrees of freedom for the Pearson chi-square
test were deﬁned as follows: (r − 1) × (c − 1), where r = the
number of rows and c =the number ofcolumns. Signiﬁcance
level was set at P<0.05. Data were analyzed using SAS 9.2
statistical software.
3. Results
3.1. Baseline Characteristics. The sample consisted of 789
adult (248 females and 541 males) patients admitted with
ACS (Table 1). Ages ranged from 28 to 96 years. A total of
88 (35%) females and 120 (22%) males had BDI-II scores of
14 or higher. Sixty percent of the patients were hospitalized
for their ﬁrst ACS event. The majority of the patients were
Caucasian males (64%), with a mean age of 61.35 years
(S.D. = 11.56). A signiﬁcantly higher percentage of females
were not married (51% for females and 27% for males, P<
0.0001), lived alone (25.5% for females and 17.6% for males,
P = 0.0098), and were less physically active (35% for females
and 24% for males, P = 0.0002) than males. More than half
of females in the study had less than high school education
(52%, P<0.0001), while the majority of males had at least
some college or college degree (60%). Females were more
likely to currently be taking antidepressants (21.3%) than
males (10.57%) (P<0.0001) and signiﬁcantly more females
(31.7%) than males (16.3%) (P<0.0001) reported a history
of depression diagnosis or treatment.
3.2. Prevalence of Self-Reported Depressive Symptoms. Results
showedthatdepressionduringACSepisodesarediﬀerentbe-
tweenmalesandfemales.Signiﬁcantlymorefemales(43.5%)
reported feeling depressed over the past year than compared
to males (27.2%). During admission for ACS, the average
BDI-II scores were signiﬁcantly higher for females (mean =
11.89, S.D. = 9.68) than that for males (mean = 9.00, S.D. =
7.93)(P<0.0001)indicatingthatthefemalesreportedgreat-
er depressive symptoms. Females reported signiﬁcantly more
sadness, self dislike, crying, indecisiveness, sleep disturbance,
appetite disturbance, and loss of interest in sex than males
(Table 2). Signiﬁcantly more females (7.66%) were identiﬁed
as positive for somatic depression symptoms (reported 1 or
higher scores on all three questions) than males (2.22%)
(P = 0.0003).Nursing Research and Practice 3
Table 1: Comparison of demographic and clinical health characteristics of acute coronary syndrome patients.
Variables (n = 789) Women (n = 248) Men (n = 541) P value
Age at consent 0.0013∗
M (year) ± SD 62.28 ±12.03 64.31 ±12.79 61.35 ±11.56
Range 28–96 29–96 32–95
BMI 0.2995
M (lb/inch2) ± SD 30.13 ±6.44 30.53 ±7.91 29.95 ±5.64
Range 16.47–58.57 16.47–61.33 18.09–58.57
BDI Score (0–63) <0.0001∗
M ± SD 9.93 ±8.63 11.98 ±9.68 9.00 ±7.93
Range 0–48 0–48 0–43
Race 0.0274∗
White 485 (61.47) 141 (56.85) 344 (63.59)
Black 152 (19.26) 63 (25.40) 89 (16.45)
Spanish/Hispanic Latino Descent 123 (15.59) 37 (14.92) 86 (15.90)
Some other race 29 (3.68) 7 (2.82) 22 (4.07)
Marital Status <0.0001∗
Single, Divorced, Separated, Widowed 272 (34.56) 126 (51.01) 146 (27.04)
Married 515 (65.44) 121 (48.99) 394 (72.96)
Living arrangement 0.0098∗
Live with spouse or family member 630 (79.95) 184 (74.49) 446 (82.44)
Live alone 158 (20.05) 63 (25.51) 95 (17.56)
Education <0.0001∗
≤High school 340 (43.26) 129 (52.23) 211 (39.15)
Some college/vocational Technical 217 (27.61) 74 (29.96) 143 (26.53)
College degree and above 229 (29.13) 44 (17.81) 185 (34.32)
Smoking 0.0054∗
Yes, currently 178 (22.62) 54 (21.77) 124 (23.01)
Yes, but quit (≤1 year) 290 (36.85) 74 (29.84) 216 (40.07)
Never 319 (40.53) 120 (48.39) 199 (36.92)
Alcohol <0.0001∗
Yes, currently 364 (46.43) 87 (35.22) 277 (51.58)
Yes, but quit (≤1 year) 87 (11.10) 14 (5.67) 73 (13.59)
Never 333 (42.47) 146 (59.11) 187 (34.82)
Activity 0.0002∗
More active 354 (45.10) 86 (34.82) 268 (49.81)
Less active 218 (27.77) 88 (35.63) 130 (24.16)
About same 213 (27.13) 73 (29.55) 140 (26.02)
Depressed (BDI ≥14) 208 (26.36) 88 (35.48) 120 (22.18) 0.0001∗
Depression questions
Current antidepressant use 108 (13.95) 52 (21.31) 56 (10.57) <0.0001∗
History of Depression feeling 251 (32.39) 107 (43.50) 144 (27.22) <0.0001∗
History of depression diagnosis or
treatment 164 (21.19) 78 (31.71) 86 (16.29) <0.0001∗
Note: values in parenthesis are percentages.
∗Statistical signiﬁcant at level of P<0.05.
4. Discussion
The prevalence of depression in this study was signiﬁcantly
higher in the females (35%) than males (22%) (BDI-II
scores ≥ 14). Of the 21 depressive symptoms evaluated by
the BDI-II, 19 depressive symptoms were reported more
frequently by females; 7 out of the 19 symptoms reaching
statistical signiﬁcance (P<0.05). Although our results sup-
port the increase in somatic symptoms in females (sleep
and appetite disturbances), as reported by Wenzel [15], self-
reported symptoms of fatigue were not statistically diﬀerent
between males and females.
Several methodological caveats must be considered when
interpreting the data. The sample was a convenient sample4 Nursing Research and Practice
Table 2: Proportional comparison of each individual BDI-II question.
BDI-II 21 questions symptom
present ≥1 All (n = 789) Females (n = 248) Males (n = 541) P value
Q1:Sadness 206 (26.14) 91 (36.69) 115 (21.30) <0.0001∗
Q2:Pessimism 245 (31.05) 86 (34.68) 159 (29.39) 0.1362
Q3:Past failure 174 (22.08) 65 (26.21) 109 (20.19) 0.0583
Q4:Loss pleasure 330 (41.83) 103 (41.53) 227 (41.96) 0.9101
Q5:Guilty feelings 217 (27.57) 79 (31.98) 138 (25.56) 0.0611
Q6:Punish feelings 95 (12.09) 33 (13.36) 62 (11.50) 0.4583
Q7:Self dislike 149 (18.93) 59 (23.98) 90 (16.64) 0.0147∗
Q8:Self criticalness 235 (29.90) 72 (29.15) 163 (30.24) 0.7564
Q9:Suicidal whish 47 (5.96) 19 (7.56) 28 (5.18) 0.1708
Q10:Crying 186 (23.66) 90 (36.59) 96 (17.78) <0.0001∗
Q11:Agitation 356 (45.12) 117 (47.18) 239 (44.18) 0.4318
Q12:Loss of interest 235 (29.78) 79 (31.85) 156 (28.84) 0.3893
Q13:Indecisiveness 193 (24.49) 76 (30.77) 117 (21.63) 0.0056∗
Q14:Worthless 136 (17.24) 52 (20.97) 84 (15.53) 0.0603
Q15:Loss of energy 579 (73.38) 193 (77.82) 386 (71.35) 0.0561
Q16:Sleep disturbance 453 (57.41) 156 (62.90) 297 (54.90) 0.0348∗
Q17:Irritability 295 (37.44) 100 (40.32) 195 (36.11) 0.2566
Q18:Appetite disturbance 313 (39.67) 121 (48.79) 192 (35.49) 0.0004∗
Q19:Concentration 330 (41.83) 115 (46.37) 215 (39.74) 0.0797
Q20:Fatigue 565 (71.61) 189 (76.21) 376 (69.50) 0.0523
Q21:Loss Interest Sex 323 (41.09) 128 (51.82) 195 (36.18) <0.0001∗
Note: values in parenthesis are percentages and BDI-II symptoms are considered present with a BDI-II score ≥1 in 0–3 scoring system.
∗Statistical signiﬁcant at level of P<0.05.
largely made up of Caucasians with a high number of males,
and participants were recruited from two large tertiary
medical centers with high levels of acuity. Although similar
patterns of somatic depressive symptoms have been re-
ported from several epidemiological studies [15–17], other
comorbid psychiatric, medical conditions, and treatments
that may aﬀect somatic symptoms should be considered.
Some of the self-reported somatic symptoms may have been
caused by the current ACS event. Despite these limitations,
results from this study raise the possibility that females may
have heterogeneous symptomology with various depression
subtypes that may aﬀect their morbidity and mortality after
ACS events.
5. Conclusion
In conclusion, results from the present study support the
hypothesis that there are gender diﬀerences in depression
prevalence and self-reported somatic depressive symptoms,
in patients hospitalized for ACS. Somatic symptoms may be
important indicators of depression among ACS patients,
especially female patients. The ability to diagnose and treat
depressioninthesepatientsisanimportantinterventionthat
would decrease subsequent ACS events. Future studies are
needed to identify the biological and psychological mecha-
nisms to explain this gender diﬀerence.
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